Business Description
Adagio Medical Holdings Inc
NAICS : 423450
SIC : 5047
ISIN : US00534B1008
Total Employee Number:
41Description
Adagio Medical Holdings Inc is a medical device company focused on developing and commercializing products for the treatment of cardiac arrhythmias with its proprietary, catheter-based Ultra-Low Temperature Ablation (ULTA) technology. UTLA is designed to create large, durable lesions extending through the depth of both diseased and healthy cardiac tissue. The company is currently focused on the treatment of ventricular tachycardia (VT), a rapid, abnormal heart rhythm, or arrhythmia, that originates in the heart's lower chambers, or ventricles. The company has one reportable segment.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.54 | |||||
Equity-to-Asset | 0.15 | |||||
Debt-to-Equity | 4.21 | |||||
Debt-to-EBITDA | -1.18 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 9.4 | |||||
3-Year EPS without NRI Growth Rate | 5.1 | |||||
3-Year FCF Growth Rate | 11.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 21.22 | |||||
9-Day RSI | 23.72 | |||||
14-Day RSI | 27.11 | |||||
3-1 Month Momentum % | -46.8 | |||||
6-1 Month Momentum % | -18.2 | |||||
12-1 Month Momentum % | -45.74 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.85 | |||||
Quick Ratio | 1.66 | |||||
Cash Ratio | 1.51 | |||||
Days Inventory | 1520.13 | |||||
Days Payable | 1233.89 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -18.4 | |||||
Shareholder Yield % | -41.86 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -321.62 | |||||
ROA % | -63.68 | |||||
ROIC % | -76.87 | |||||
3-Year ROIIC % | 16.86 | |||||
ROC (Joel Greenblatt) % | -825.3 | |||||
ROCE % | -69.33 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PB Ratio | 2.04 | |||||
EV-to-EBIT | -1.08 | |||||
EV-to-EBITDA | -1.12 | |||||
EV-to-FCF | -1.44 | |||||
Earnings Yield (Greenblatt) % | -92.59 | |||||
FCF Yield % | -135.41 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ADGM
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Adagio Medical Holdings Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -1.53 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 76.95 | ||
| 14-Day RSI | 27.11 | ||
| 14-Day ATR ($) | 0.05617 | ||
| 20-Day SMA ($) | 0.628995 | ||
| 12-1 Month Momentum % | -45.74 | ||
| 52-Week Range ($) | 0.5301 - 2.582 | ||
| Shares Outstanding (Mil) | 22.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Adagio Medical Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Adagio Medical Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| General meeting for 2026 | 2026-12-15 13:00 | In 153 days | ||
| Third quarter earnings results for 2026 | 2026-11-12 | In 119 days | ||
| Second quarter earnings results for 2026 | 2026-08-14 | In 29 days | ||
| First quarter earnings results for 2026 | 2026-05-12 | 0.94 (-3.09%) | ||
| Annual report for 2025 | 2026-03-27 | 1.24 (+0.81%) | ||
| Fourth quarter earnings results for 2025 | 2026-03-27 | 1.24 (+0.81%) | ||
| General meeting for 2025 | 2025-12-15 13:00 | 0.98 (+11.48%) | ||
| Third quarter earnings results for 2025 | 2025-11-12 | 0.87 (+3.51%) | ||
| Second quarter earnings results for 2025 | 2025-08-14 | 1.27 (-0.78%) | ||
| First quarter earnings results for 2025 | 2025-05-15 | 1.22 (-3.94%) |
Show
Entries
Adagio Medical Holdings Inc Frequently Asked Questions
What is Adagio Medical Holdings Inc(ADGM)'s stock price today?
The current price of ADGM is $0.53. The 52 week high of ADGM is $2.58 and 52 week low is $0.53.
When is next earnings date of Adagio Medical Holdings Inc(ADGM)?
The next earnings date of Adagio Medical Holdings Inc(ADGM) is 2026-08-14 Est..
Does Adagio Medical Holdings Inc(ADGM) pay dividends? If so, how much?
Adagio Medical Holdings Inc(ADGM) does not pay dividend.
Guru Commentaries on NAS:ADGM
No articles.
Press Release
Articles on Adagio Medical Holdings Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers